JALEN BOYD: Open Payments
NPI 1528682556 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $539 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 2 | $164 |
| Abbott Laboratories | 1 | $136 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Alexion Pharmaceuticals, Inc. | 3 | $85 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: iLet Bionic Pancreas, FREESTYLE LIBRE 3, JYNARQUE, ULTOMIRIS, LUPKYNIS, Kerendia, VOYXACT, BENLYSTA.
Industry payments across IL — which companies pay providers there.
